Uncategorized
Valeant quarterly revenue totals $2.1 billion
Valeant Pharmaceuticals reported $2.1 billion in revenue in its third quarter, an increase of 33% compared with the third quarter 2013, according to a press release.Quarterly net income totaled $276.4 million, compared with a net loss of $971.9 million in 2013.